Caseware UK (AP4) 2023.0.135 2023.0.135 false1true12022-11-01No description of principal activityThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 10408413 2022-11-01 2023-10-31 10408413 2021-11-01 2022-10-31 10408413 2023-10-31 10408413 2022-10-31 10408413 c:Director1 2022-11-01 2023-10-31 10408413 d:CurrentFinancialInstruments 2023-10-31 10408413 d:CurrentFinancialInstruments 2022-10-31 10408413 c:AuditExemptWithAccountantsReport 2022-11-01 2023-10-31 10408413 c:FullAccounts 2022-11-01 2023-10-31 10408413 c:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 10408413 c:Micro-entities 2022-11-01 2023-10-31 10408413 e:PoundSterling 2022-11-01 2023-10-31 iso4217:GBP xbrli:pure

Registered number: 10408413










East Kent Pharma Consulting Ltd








Unaudited

Financial statements

Information for filing with the registrar

For the Year Ended 31 October 2023





 
East Kent Pharma Consulting Ltd
 
  
Chartered Accountants' Report to the Director on the preparation of the Unaudited Statutory Financial Statements of East Kent Pharma Consulting Ltd for the Year Ended 31 October 2023

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of East Kent Pharma Consulting Ltd for the year ended 31 October 2023 which comprise  the Balance Sheet and the related notes from the Company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW)we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com /regulation.

This report is made solely to the director of East Kent Pharma Consulting Ltd in accordance with the terms of our engagement letter dated 4 May 2021Our work has been undertaken solely to prepare for your approval the financial statements of East Kent Pharma Consulting Ltd  and state those matters that we have agreed to state to the director of East Kent Pharma Consulting Ltd in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than East Kent Pharma Consulting Ltd and its director for our work or for this report. 

It is your duty to ensure that East Kent Pharma Consulting Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of East Kent Pharma Consulting Ltd. You consider that East Kent Pharma Consulting Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of East Kent Pharma Consulting Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  



Kreston Reeves LLP
 
Chartered Accountants
  
37 St Margaret's Street
Canterbury
Kent
CT1 2TU
17 January 2024
Page 1

 
East Kent Pharma Consulting Ltd
Registered number: 10408413

Balance Sheet
As at 31 October 2023

2023
2022
£
£


Fixed assets
8,061
1,042

Current assets
24,999
30,945

Creditors: amounts falling due within one year
(2,957)
(2,923)

Net current assets
 
 
22,042
 
 
28,022


Net assets
30,103
29,064



Capital and reserves
30,103
29,064


Notes


General information

East Kent Pharma Consulting Limited is a private limited company by shares and is incorporated in England and Wales with the registration number 10408413.
The address of the registered office is Cloth Fair, High Street, Earls Colne, Colchester, Essex, CO6 2QX. 
The financial statements are presented in pounds Sterling, and are rounded to the nearest pound. 


Average number of employees

The average monthly number of employees, including directors, during the year was 1 (2022 - 1).

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 17 January 2024.




Dr A J Fleetwood
Director


Page 2